JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) EBIT per Share : ฿0.10 (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is JSP Pharmaceutical Manufacturing (Thailand) PCL EBIT per Share?

JSP Pharmaceutical Manufacturing (Thailand) PCL's EBIT per Share for the three months ended in Mar. 2024 was ฿0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ฿0.10.

During the past 12 months, the average EBIT per Share Growth Rate of JSP Pharmaceutical Manufacturing (Thailand) PCL was -212.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for JSP Pharmaceutical Manufacturing (Thailand) PCL's EBIT per Share or its related term are showing as below:

BKK:JSP-F's 3-Year EBIT Growth Rate is not ranked ^*
in the Consumer Packaged Goods industry.
Industry Median: 5.9
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

JSP Pharmaceutical Manufacturing (Thailand) PCL's EBIT for the three months ended in Mar. 2024 was ฿0.24 Mil.

JSP Pharmaceutical Manufacturing (Thailand) PCL EBIT per Share Historical Data

The historical data trend for JSP Pharmaceutical Manufacturing (Thailand) PCL's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JSP Pharmaceutical Manufacturing (Thailand) PCL EBIT per Share Chart

JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

0.10

0.11

0.13

0.02

0.10

JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial										-	-0.03	0.10	0.02	-

JSP Pharmaceutical Manufacturing (Thailand) PCL EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

JSP Pharmaceutical Manufacturing (Thailand) PCL's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	50.548	/	525.091
=	0.10

JSP Pharmaceutical Manufacturing (Thailand) PCL's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0.243	/	474.555
=	0.00

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.10

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

JSP Pharmaceutical Manufacturing (Thailand) PCL EBIT per Share Related Terms

Thank you for viewing the detailed overview of JSP Pharmaceutical Manufacturing (Thailand) PCL's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 255 and 257, Soi Sathupradit, 58, Bang Pongphang, Yannawa, Bangkok, THA, 10120

Website

https://www.jsppharma.com

JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing drugs, dietary supplements, cosmetics, herbs, and dietary supplements in the form of vitamins including healthy coffee Ready. Its segments include Manufacturing and distribution of products under the customer's Brand name and Own Brand name. The majority of the revenue comes from the manufacturing and distribution of products under the customer's brand name. The Group is managed and operates principally in Thailand.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Headlines

No Headlines